Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Safety profile

Safety Issue:

Yes

Principal Investigator

Georg Høyer, DH

Investigator Role:

Study Chair

Investigator Affiliation:

South region committee for research ethics in Norway

Authority:

Norway: Norwegian Medicines Agency

Study ID:

S-05059

NCT ID:

NCT00278694

Start Date:

September 2005

Completion Date:

May 2013

Related Keywords:

• Rectal Cancer
• Oxaliplatin, radiation
• Rectal Neoplasms

Name	Location